Pent-up private Wegovy demand prompts UK availability concerns

[1/3] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights LONDON, Sept 4 (Reuters) - People in Britain who can afford to pay out of their…#novonordisk #oslo #norway #nhs #wegovy #novo #naveedsattar #universityofglasgow #oecd #obese
Source: Reuters: Health - Category: Consumer Health News Source Type: news